Literature DB >> 28634880

Erratum to: An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin.

Abdelmjid Chraibi1,2, Shoorook Al-Herz3, Bich Dao Nguyen4, Djoko W Soeatmadji5, Anil Shinde6, Balasubramanian Lakshmivenkataraman7, Samir H Assaad-Khalil8.   

Abstract

Entities:  

Year:  2017        PMID: 28634880      PMCID: PMC5544612          DOI: 10.1007/s13300-017-0275-2

Source DB:  PubMed          Journal:  Diabetes Ther            Impact factor:   2.945


× No keyword cloud information.

Erratum to: Diabetes Ther DOI 10.1007/s13300-017-0268-1

Published version of this article contains incorrect labeling in Fig. 3.
Fig. 3

a Mean change from baseline FPG (LOCF); b 7-point SMPG profiles from baseline and after 20 weeks of treatment (EOT); c total daily insulin dose. Data from FAS. EOT end of trial, FPG fasting plasma glucose, LOCF last observation carried forward, SMPG self-measured plasma glucose

a Mean change from baseline FPG (LOCF); b 7-point SMPG profiles from baseline and after 20 weeks of treatment (EOT); c total daily insulin dose. Data from FAS. EOT end of trial, FPG fasting plasma glucose, LOCF last observation carried forward, SMPG self-measured plasma glucose Label on the x-axis of Fig. 3b currently read: ‘90 min before breakfast’, ‘90 min before lunch’ and ‘90 min before dinner’. These labels should read ‘90 min after breakfast’, ‘90 min after lunch’ and ‘90 min after dinner’.
  1 in total

Review 1.  15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.

Authors:  Andreas Liebl; Viswanathan Mohan; Wenying Yang; Krzysztof Strojek; Sultan Linjawi
Journal:  Drugs R D       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.